According to HealthSouth 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.72114. At the end of 2023 the company had a P/S ratio of 1.39.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.39 | 1.5% |
2022 | 1.37 | 2.47% |
2021 | 1.34 | -24.34% |
2020 | 1.77 | 19.37% |
2019 | 1.48 | 3.93% |
2018 | 1.43 | 15.02% |
2017 | 1.24 | 22.16% |
2016 | 1.02 | 0.87% |
2015 | 1.01 | -29.19% |
2014 | 1.42 | 8.99% |
2013 | 1.30 | 36.62% |
2012 | 0.9550 | 14.45% |
2011 | 0.8345 | -16.36% |
2010 | 0.9977 | 8.52% |
2009 | 0.9193 | 75.36% |
2008 | 0.5243 | -44.39% |
2007 | 0.9428 | 6.71% |
2006 | 0.8835 | 46.9% |
2005 | 0.6014 | |
2002 | 0.3862 | -70.9% |
2001 | 1.33 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Select Medical Holdings SEM | 0.5281 | -69.32% | ๐บ๐ธ USA |
HealthSouth
EHC | 1.72 | 0.00% | ๐บ๐ธ USA |
Novo Integrated Sciences NVOS | 0.7377 | -57.14% | ๐บ๐ธ USA |